Citation: Rk. Bruton et al., THE GROUP-1 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST DHPG ELEVATES STRIATAL DOPAMINE RELEASE IN THE RAT IN-VIVO, British Journal of Pharmacology, 118, 1996, pp. 73-73
Citation: Rk. Bruton et al., EVALUATION OF IN-VIVO STRIATAL DOPAMINE RELEASE IN THE RAT VIA ACTIVATION OF METABOTROPIC GLUTAMATE RECEPTORS, British Journal of Pharmacology, 117, 1996, pp. 294-294
Authors:
STEWARD LJ
GE J
STOWE RL
BROWN DC
BRUTON RK
STOKES PRA
BARNES NM
Citation: Lj. Steward et al., ABILITY OF 5-HT4 RECEPTOR LIGANDS TO MODULATE RAT STRIATAL DOPAMINE RELEASE IN-VITRO AND IN-VIVO, British Journal of Pharmacology, 117(1), 1996, pp. 55-62
Authors:
BRUTON CJ
BRUTON RK
GENTLEMAN SM
ROBERTS GW
Citation: Cj. Bruton et al., DIAGNOSIS AND INCIDENCE OF PRION (CREUTZFELDT-JAKOB) DISEASE - A RETROSPECTIVE ARCHIVAL SURVEY WITH IMPLICATIONS FOR FUTURE-RESEARCH, Neurodegeneration, 4(4), 1995, pp. 357-368
Authors:
BRUTON CJ
BRUTON RK
GENTLEMAN SM
ROBERTS GW
Citation: Cj. Bruton et al., PRION (CREUTZFELDT-JAKOB) DISEASE - A RETROSPECTIVE NEUROPATHOLOGICALINVESTIGATION WITH IMPLICATIONS FOR FUTURE-RESEARCH, Neurobiology of aging, 15, 1994, pp. 190000088-190000088
Authors:
ROBERTS GW
BRUTON CJ
BRUTON RK
GENTLEMAN SM
Citation: Gw. Roberts et al., DIAGNOSIS AND INCIDENCE OF PRION (CREUTZFELDT-JAKOB) DISEASE - A RETROSPECTIVE ARCHIVAL SURVEY, Neurobiology of aging, 15, 1994, pp. 190000156-190000156